[go: up one dir, main page]

WO2008133196A1 - Matériau pour la médecine régénérative - Google Patents

Matériau pour la médecine régénérative Download PDF

Info

Publication number
WO2008133196A1
WO2008133196A1 PCT/JP2008/057574 JP2008057574W WO2008133196A1 WO 2008133196 A1 WO2008133196 A1 WO 2008133196A1 JP 2008057574 W JP2008057574 W JP 2008057574W WO 2008133196 A1 WO2008133196 A1 WO 2008133196A1
Authority
WO
WIPO (PCT)
Prior art keywords
regenerative medicine
matrix
genetically modified
modified gelatin
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/057574
Other languages
English (en)
Japanese (ja)
Inventor
Shouji Ooya
Takayuki Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of WO2008133196A1 publication Critical patent/WO2008133196A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne un matériau pour la médecine régénérative qui permet de réduire le risque de provoquer une infection dans un peptide de type collagène, et d'élaborer de façon précise des paramètres nécessaires pour une matrice destinée à la médecine régénérative. Spécifiquement, la présente invention décrit un matériau pour la médecine régénérative qui comprend une gélatine modifiée génétiquement. La gélatine modifiée génétiquement est mise en contact avec un tissu biologique sous la forme d'une matrice.
PCT/JP2008/057574 2007-04-19 2008-04-18 Matériau pour la médecine régénérative Ceased WO2008133196A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-110041 2007-04-19
JP2007110041 2007-04-19

Publications (1)

Publication Number Publication Date
WO2008133196A1 true WO2008133196A1 (fr) 2008-11-06

Family

ID=39925650

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/057574 Ceased WO2008133196A1 (fr) 2007-04-19 2008-04-18 Matériau pour la médecine régénérative

Country Status (1)

Country Link
WO (1) WO2008133196A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010128672A1 (fr) * 2009-05-07 2010-11-11 富士フイルム株式会社 Inducteur de néovascularisation comprenant de la gélatine recombinée génétiquement
WO2011027850A1 (fr) * 2009-09-04 2011-03-10 富士フイルム株式会社 Agent de régénération osseuse comprenant de la gélatine
JP2012219100A (ja) * 2011-04-12 2012-11-12 Fujifilm Corp 細胞と生体適合性高分子を含む組成物
CN102791301A (zh) * 2010-03-02 2012-11-21 富士胶片株式会社 细胞支持体和骨再生材料
JP2013074936A (ja) * 2011-09-29 2013-04-25 Fujifilm Corp 血管内皮細胞遊走用足場
JP2014012114A (ja) * 2011-08-31 2014-01-23 Fujifilm Corp 細胞移植用細胞構造体および細胞移植用細胞集合体
WO2014050908A1 (fr) 2012-09-26 2014-04-03 富士フイルム株式会社 Polypeptide, composition d'échafaudage, composition de restauration de tissu cartilagineux, composition de culture de cellules cartilagineuses et composition de promotion de la production de glycosaminoglycane
JP2016174538A (ja) * 2015-03-18 2016-10-06 富士フイルム株式会社 管状構造物、細胞構造体の製造方法、及び管状構造物の製造方法
CN111704663A (zh) * 2020-06-29 2020-09-25 江南大学 一种胶原蛋白水凝胶的制备方法
CN111793127A (zh) * 2020-06-17 2020-10-20 江南大学 一种iii型类人胶原蛋白及其编码基因、重组菌与应用
CN112661856A (zh) * 2020-08-20 2021-04-16 点斗基因科技(南京)有限公司 一种elp类胶原蛋白的纯化方法及应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03502935A (ja) * 1988-11-09 1991-07-04 プロテイン　ポリマー　テクノロジーズ，インコーポレイティド 組換え的に調製された官能的な合成タンパク質ポリマー
JP2001502548A (ja) * 1996-10-29 2001-02-27 コモンウェルス サイエンティフィック アンド アンダストリアル リサーチ オーガニゼーション 三重らせんタンパク質の安定発現
JP2003516730A (ja) * 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド 組換えゼラチン
WO2004085473A2 (fr) * 2003-03-28 2004-10-07 Fuji Photo Film B.V. Proteines de type enrichi de rgd (arginine-glycine-acide aspartique) a liaison cellulaire amelioree
JP2007277217A (ja) * 2006-03-17 2007-10-25 Fujifilm Corp 薬剤を均一に封入した生分解性マトリックス

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03502935A (ja) * 1988-11-09 1991-07-04 プロテイン　ポリマー　テクノロジーズ，インコーポレイティド 組換え的に調製された官能的な合成タンパク質ポリマー
JP2001502548A (ja) * 1996-10-29 2001-02-27 コモンウェルス サイエンティフィック アンド アンダストリアル リサーチ オーガニゼーション 三重らせんタンパク質の安定発現
JP2003516730A (ja) * 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド 組換えゼラチン
WO2004085473A2 (fr) * 2003-03-28 2004-10-07 Fuji Photo Film B.V. Proteines de type enrichi de rgd (arginine-glycine-acide aspartique) a liaison cellulaire amelioree
JP2007277217A (ja) * 2006-03-17 2007-10-25 Fujifilm Corp 薬剤を均一に封入した生分解性マトリックス

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5752033B2 (ja) * 2009-05-07 2015-07-22 富士フイルム株式会社 遺伝子組み換えゼラチンを含む血管新生誘導剤
WO2010128672A1 (fr) * 2009-05-07 2010-11-11 富士フイルム株式会社 Inducteur de néovascularisation comprenant de la gélatine recombinée génétiquement
US9968661B2 (en) 2009-09-04 2018-05-15 Fujifilm Corporation Bone regeneration agent including gelatin
WO2011027850A1 (fr) * 2009-09-04 2011-03-10 富士フイルム株式会社 Agent de régénération osseuse comprenant de la gélatine
CN102625717A (zh) * 2009-09-04 2012-08-01 富士胶片株式会社 包含明胶的骨再生剂
US8987204B2 (en) 2009-09-04 2015-03-24 Fujifilm Coporation Bone regeneration agent comprising gelatin
CN102625717B (zh) * 2009-09-04 2016-03-16 富士胶片株式会社 包含明胶的骨再生剂
JP2015033635A (ja) * 2009-09-04 2015-02-19 富士フイルム株式会社 遺伝子組み換えゼラチンを含む肉芽組織形成剤
JP5642685B2 (ja) * 2009-09-04 2014-12-17 富士フイルム株式会社 ゼラチンを含む骨再生剤
US9101686B2 (en) 2010-03-02 2015-08-11 Fujifilm Corporation Cell support and bone regeneration material
CN102791301A (zh) * 2010-03-02 2012-11-21 富士胶片株式会社 细胞支持体和骨再生材料
JP2012219100A (ja) * 2011-04-12 2012-11-12 Fujifilm Corp 細胞と生体適合性高分子を含む組成物
JP2016188235A (ja) * 2011-04-12 2016-11-04 富士フイルム株式会社 細胞と生体適合性高分子を含む組成物
US10406183B2 (en) 2011-04-12 2019-09-10 Fujifilm Corporation Composition comprising cell and biocompatible polymer
JP2014012114A (ja) * 2011-08-31 2014-01-23 Fujifilm Corp 細胞移植用細胞構造体および細胞移植用細胞集合体
JP2013074936A (ja) * 2011-09-29 2013-04-25 Fujifilm Corp 血管内皮細胞遊走用足場
EP2578246A3 (fr) * 2011-09-29 2015-01-14 Fujifilm Corporation Structure pour la migration de cellules endothéliales vasculaires
US9932557B2 (en) 2012-09-26 2018-04-03 Fujifilm Corporation Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production
WO2014050908A1 (fr) 2012-09-26 2014-04-03 富士フイルム株式会社 Polypeptide, composition d'échafaudage, composition de restauration de tissu cartilagineux, composition de culture de cellules cartilagineuses et composition de promotion de la production de glycosaminoglycane
JP2016174538A (ja) * 2015-03-18 2016-10-06 富士フイルム株式会社 管状構造物、細胞構造体の製造方法、及び管状構造物の製造方法
CN111793127A (zh) * 2020-06-17 2020-10-20 江南大学 一种iii型类人胶原蛋白及其编码基因、重组菌与应用
CN111793127B (zh) * 2020-06-17 2021-11-02 江南大学 一种iii型类人胶原蛋白及其编码基因、重组菌与应用
CN111704663A (zh) * 2020-06-29 2020-09-25 江南大学 一种胶原蛋白水凝胶的制备方法
CN112661856A (zh) * 2020-08-20 2021-04-16 点斗基因科技(南京)有限公司 一种elp类胶原蛋白的纯化方法及应用

Similar Documents

Publication Publication Date Title
WO2008133196A1 (fr) Matériau pour la médecine régénérative
ES2422739T3 (es) Composición para el diagnóstico, prevención o tratamiento de enfermedades relacionadas con células que expresan IL-8 o GRO-, que comprende MSC de UCB
EP2102927A4 (fr) Matériau actif pour cathode en spinelle coeur-écorce utilisée dans des batteries secondaires au lithium, batteries secondaires les comprenant et procédé de préparation associé
NZ593364A (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
WO2008103041A8 (fr) Gélatines de recombinaison
WO2010008739A3 (fr) Agonistes des récepteurs gpr119 aryles et utilisations associées
UA108598C2 (xx) Високоефективні кон'югати та гідрофільні зшиваючі агенти (лінкери)
SG196838A1 (en) Gpr120 receptor agonists and uses thereof
FR2903702B1 (fr) Equivalent d'epiderme capable de se pigmenter obtenu a partir de cellules de la matrice, procede de preparation et utilisation
MX2008014679A (es) Ensayos para diagnosticar y evaluar opciones de tratamiento para enfermedad de fabry.
HUE058891T2 (hu) Módszer és készítmények a T-sejtek fokozott tumorellenes effektor mûködésének fokozására
CL2012002416A1 (es) Proteina de union capaz de unirse a dll4; construccion de anticuerpo que comprende dicha proteina; conjugado de anticuerpo; acido nucleico, vector y celula huesped que comprenden el anticuerpo; composicion para la liberacion de una proteina de union; metodo para reducir la actividad del dll4 humano.
AR077333A1 (es) Anticuerpos humanos de alta afinidad para la angiopoyetina -2 humana
WO2010048207A3 (fr) Agonistes de récepteur gpr120 aryl et utilisations de ceux-ci
BRPI0819649A2 (pt) método, organismo geneticamente modificado, e, célula de levedura recinbinante
NZ593365A (en) Pharmaceutical preparation comprising a blood mononuclear cell culture
EP2215262A4 (fr) Contrôle de la glycémie en vue de réduire le risque de maladies cardio-vasculaires chez les patients diabétiques exprimant l'haptoglobine 2-2
WO2010073152A3 (fr) Récipient de stérilisation à usage unique
WO2009114712A3 (fr) Analyses permettant de diagnostiquer et d’évaluer des options de traitement pour la maladie de pompe
WO2013056049A3 (fr) Prothèses tubulaires
WO2012050896A3 (fr) Ensembles supramoléculaires à site de protéase sélectifs
WO2007109733A3 (fr) Marqueurs de diagnostic et de pronostic et strategies de traitement de la sclerose en plaques
WO2006104866A3 (fr) Gant a adherence controlee
NZ601735A (en) Antibody with binding specificity for Nedd4 protein for reducing influenza infectivity
IL203762A (en) Use of collagen-containing preparation for biological cell growth

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08740629

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08740629

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP